AEGON Company Profile (AMS:AGN)

About AEGON (AMS:AGN)

AEGON logoAegon N.V. (Aegon) is an international life insurance, pensions and asset management company. The Company's segments include the Americas, which includes the United States, Mexico and Brazil; the Netherlands; the United Kingdom; Central & Eastern Europe; Spain & Portugal; Asia, and Aegon Asset Management. It offers protection against mortality, morbidity and longevity risks, including traditional and universal life. It offers products with mortality, morbidity, and longevity risks, including traditional and universal life; mortgages; annuity products, and banking products. It offers individual protection products, such as annuities, term insurance, income protection and international/offshore bonds. It has activities in the Czech Republic, Hungary, Poland, Romania, Slovakia and Turkey. It offers life insurance marketed to high-net-worth individuals in Hong Kong and Singapore. It also offers investment products covering third-party customers, insurance-linked solutions.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: €241.06
  • 200 Day Moving Avg: €235.56
P/E:
  • Trailing P/E Ratio: 7.90
  • P/E Growth: 1.16
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 2.42%
  • Return on Equity: 5.50%
  • Return on Assets: 0.36%
 
Frequently Asked Questions for AEGON (AMS:AGN)

What is AEGON's stock symbol?

AEGON trades on the AMS under the ticker symbol "AGN."

Who are some of AEGON's key competitors?

Who are AEGON's key executives?

AEGON's management team includes the folowing people:

  • Robert J. Routs, Chairman of the Supervisory Board
  • Alexander Rijn Wynaendts, Chief Executive Officer, Chairman of the Executive Board, Chairman of the Management Board
  • Mark Bloom, Member of the Management Board, Chief Technology Officer
  • Allegra Van Hovell-Patrizi, Member of the Management Board, Chief Risk Officer
  • Onno van Klinken, Member of the Management Board, General Counsel
  • Carla Mahieu, Member of the Management Board, Global Head Human Resources
  • Adrian Grace, Member of the Management Board, Chief Executive Officer of Aegon UK
  • Marco B. A. Keim, Member of the Management Board, Chief Executive Officer of Aegon the Netherlands
  • Gabor Kepecs, Member of the Management Board, Chief Executive Officer of Aegon Central & Eastern Europe
  • Mark Mullin, Member of the Management Board, Chief Executive Officer of Aegon Americas


MarketBeat Community Rating for AEGON (AMS AGN)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  68
MarketBeat's community ratings are surveys of what our community members think about AEGON and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AEGON (AMS:AGN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for AEGON (AMS:AGN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for AEGON (AMS:AGN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for AEGON (AMS:AGN)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for AEGON (AMS:AGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AEGON (AMS:AGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for AEGON (AMS:AGN)
Latest Headlines for AEGON (AMS:AGN)
Source:
DateHeadline
finance.yahoo.com logoPawar Law Group Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN
finance.yahoo.com - July 24 at 6:42 PM
finance.yahoo.com logoTrump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says
finance.yahoo.com - July 22 at 3:32 PM
finance.yahoo.com logoTrump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says
finance.yahoo.com - July 22 at 3:32 PM
finance.yahoo.com logoInside Allergan’s Developments in 2Q17
finance.yahoo.com - July 13 at 9:22 PM
finance.yahoo.com logoCramer: Mea culpa! This stock's action is why I say small...
finance.yahoo.com - July 13 at 9:22 PM
finance.yahoo.com logoAs Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals
finance.yahoo.com - July 11 at 4:47 PM
finance.yahoo.com logoAllergan Reports New Data Reinforcing the Effectiveness of Viberzi® (Eluxadoline) to Treat the Symptoms Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D), Abdominal Pain and Diarrhea
finance.yahoo.com - July 10 at 3:19 PM
finance.yahoo.com logoSarepta: A New CEO Goes a Long Way?
finance.yahoo.com - June 29 at 4:23 PM
finance.yahoo.com logoSarepta Appoints Ex-Allergan Executive as CEO and President
finance.yahoo.com - June 29 at 4:23 PM
finance.yahoo.com logoCould This Biotech Be Headed For A Deal After CEO Takes Reins?
finance.yahoo.com - June 29 at 4:23 PM
finance.yahoo.com logoSarepta appoints former Allergan executive Douglas Ingram as CEO
finance.yahoo.com - June 28 at 8:51 PM
finance.yahoo.com logo[$$] Sarepta Taps Chase Pharmaceuticals Chief as Next CEO
finance.yahoo.com - June 28 at 8:51 PM
finance.yahoo.com logoDillard's Is One of the Best Long-Term Investments in Retail, Doug Kass Says
finance.yahoo.com - June 26 at 8:55 PM
finance.yahoo.com logoCramer: If There's No Reason for a Rally, Then Something's Wrong
finance.yahoo.com - June 20 at 9:10 PM
finance.yahoo.com logoNew migraine drugs have promise — and a $8,500 price tag
finance.yahoo.com - June 9 at 3:33 PM
finance.yahoo.com logoAllergan to Buy Keller Funnel, Boost Plastic Surgery Unit
finance.yahoo.com - June 8 at 3:40 PM
finance.yahoo.com logoValeant Pharmaceuticals: Bigger is Better
finance.yahoo.com - June 8 at 3:40 PM
finance.yahoo.com logoAllergan Announces Closing of Public Offering of Senior Notes to Refinance Existing Debt
finance.yahoo.com - May 26 at 3:34 PM
finance.yahoo.com logoAllergan Announces Pricing of Tender Offers by Certain Subsidiaries
finance.yahoo.com - May 25 at 1:40 AM
uk.finance.yahoo.com logoSpanish stocks lag Europe on political worries but fresh M&A helps - Yahoo Finance UK
uk.finance.yahoo.com - May 22 at 3:26 PM
nasdaq.com logoAegon To Divest Majority Of Its US Run-off Businesses - Quick Facts
www.nasdaq.com - May 22 at 6:35 AM
finance.yahoo.com logoEarnings Are Still Calling the Tune: Cramer's 'Mad Money' Recap (Friday 5/12/17)
finance.yahoo.com - May 12 at 8:57 PM
rttnews.com logoEARNINGS SUMMARY: Details of Aegon NV Q1 Earnings Report
www.rttnews.com - May 11 at 3:40 PM
nasdaq.com logoAegon Q1 Net Income Rises; Total Sales Up 11% - Quick Facts
www.nasdaq.com - May 11 at 3:40 PM
finance.yahoo.com logo4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning
finance.yahoo.com - May 10 at 8:34 PM
finance.yahoo.com logoBehind Allergan’s US Specialized Therapeutics Segment in 1Q17
finance.yahoo.com - May 10 at 8:34 PM
finance.yahoo.com logo[$$] Thin Is In as Allergan Dodges Generics Bullet
finance.yahoo.com - May 9 at 8:24 PM
finance.yahoo.com logoEarnings Preview: What To Expect From Allergan On Tuesday
finance.yahoo.com - May 7 at 3:26 PM
finance.yahoo.com logoAllergan Announces Second Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share
finance.yahoo.com - May 5 at 3:24 PM
finance.yahoo.com logoAllergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : April 28, 2017
finance.yahoo.com - April 28 at 4:20 PM
finance.yahoo.com logoAllergan Successfully Completes ZELTIQ® Aesthetics Acquisition
finance.yahoo.com - April 28 at 4:20 PM
finance.yahoo.com logoTeva Confirms CFO Is Leaving
finance.yahoo.com - April 26 at 3:36 PM
finance.yahoo.com logoAllergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston
finance.yahoo.com - April 20 at 8:27 PM
finance.yahoo.com logoA Healthcare Pick That's Moderately Shielded From Upheaval
finance.yahoo.com - April 17 at 6:39 AM
finance.yahoo.com logoWhy Charlie Munger Hates Value Investing
finance.yahoo.com - April 13 at 8:44 PM
finance.yahoo.com logoCramer Remix: Why a slew of IPOs might not be a good thin...
finance.yahoo.com - April 11 at 8:25 PM
finance.yahoo.com logoThe Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17)
finance.yahoo.com - April 11 at 8:25 PM
finance.yahoo.com logoAllergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoNovartis Licenses ECF843 Eye Drops From Lubris
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoAllergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : April 6, 2017
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoAllergan (AGN) Presents Mixed Depression Data on Botox
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logo[$$] Investors question Allergan move to test Botox for depression
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoAllergan's Botox Studied as Depression Treatment
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoAllergan Guilty of Wishful Botox Thinking
finance.yahoo.com - April 7 at 7:08 AM
finance.yahoo.com logoAllergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy
finance.yahoo.com - April 7 at 7:08 AM
uk.finance.yahoo.com logoEuropean shares inch lower before U.S. healthcare vote
uk.finance.yahoo.com - March 24 at 9:43 AM
investopedia.com logoInsys Therapeutics' Syndros Gets Final DEA Rule
www.investopedia.com - March 23 at 3:35 PM
bizjournals.com logo​Latest Editas research pact could be worth up to $1 billion
www.bizjournals.com - March 22 at 3:25 PM
investopedia.com logoAllergan Stock Reacts Well In Downtrodden Sector
www.investopedia.com - March 22 at 3:25 PM
finance.yahoo.com logoFDA Links Breast Implants To A Rare Form Of Cancer
finance.yahoo.com - March 21 at 8:46 PM

Social

Social activity is not available for this stock.
This page was last updated on 7/25/2017 by MarketBeat.com Staff